Skip to main navigation Skip to search Skip to main content

Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders

  • Daniel Hsiang-Te Tsai
  • , J Simon Bell
  • , Shahab Abtahi
  • , Brenda N Baak
  • , Marloes T Bazelier
  • , Ruth Brauer
  • , Adrienne Y L Chan
  • , Esther W Chan
  • , Haoqian Chen
  • , Celine S L Chui
  • , Sharon Cook
  • , Stephen Crystal
  • , Poonam Gandhi
  • , Sirpa Hartikainen
  • , Frederick K Ho
  • , Shao-Ti Hsu
  • , Jenni Ilomäki
  • , Ju Hwan Kim
  • , Olaf H Klungel
  • , Marjaana Koponen
  • Wallis C Y Lau, Kui Kai Lau, Terry Y S Lum, Hao Luo, Kenneth K C Man, Jill P Pell, Soko Setoguchi, Shih-Chieh Shao, Chin-Yao Shen, Ju-Young Shin, Patrick C Souverein, Anna-Maija Tolppanen, Li Wei, Ian C K Wong, Edward Chia-Cheng Lai
  • National Cheng Kung University
  • Monash University
  • PHARMO Institute for Drug Outcomes Research
  • UCL School of Pharmacy
  • Hong Kong Science Park
  • Rutgers - The State University of New Jersey, Newark
  • University of Eastern Finland
  • University of Glasgow
  • Sungkyunkwan University
  • Open University of Hong Kong

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

PURPOSE: To describe and categorize detailed components of databases in the Neurological and Mental Health Global Epidemiology Network (NeuroGEN).

METHODS: An online 132-item questionnaire was sent to key researchers and data custodians of NeuroGEN in North America, Europe, Asia and Oceania. From the responses, we assessed data characteristics including population coverage, data follow-up, clinical information, validity of diagnoses, medication use and data latency. We also evaluated the possibility of conversion into a common data model (CDM) to implement a federated network approach. Moreover, we used radar charts to visualize the data capacity assessments, based on different perspectives.

RESULTS: The results indicated that the 15 databases covered approximately 320 million individuals, included in 7 nationwide claims databases from Australia, Finland, South Korea, Taiwan and the US, 6 population-based electronic health record databases from Hong Kong, Scotland, Taiwan, the Netherlands and the UK, and 2 biomedical databases from Taiwan and the UK.

CONCLUSION: The 15 databases showed good potential for a federated network approach using a common data model. Our study provided publicly accessible information on these databases for those seeking to employ real-world data to facilitate current assessment and future development of treatments for neurological and mental disorders.

Original languageEnglish
Pages (from-to)1241-1252
Number of pages12
JournalClinical Epidemiology
Volume2023
Issue number15
DOIs
Publication statusPublished - 21 Dec 2023

Bibliographical note

Publisher Copyright:
© 2023 Tsai et al. This work is published and licensed by Dove Medical.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • NeuroGEN
  • Neurological and Mental Health Global Epidemiology Network
  • data repository
  • meta-data

Fingerprint

Dive into the research topics of 'Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders'. Together they form a unique fingerprint.

Cite this